World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
43023
World Ranking
10306
National Ranking
5301

Overview

Ariel E. Feldstein is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology, with a particular emphasis on hepatology and epidemiology within these fields.

The scientist's work encompasses several specialized subfields, including:

  • Epidemiology
  • Hepatology
  • Molecular Biology
  • Immunology
  • Endocrinology, Diabetes and Metabolism

Their main topics of research cover a broad range of aspects related to liver diseases and immune system functions. The principal topics are:

  • Liver Disease Diagnosis and Treatment
  • Inflammasome and immune disorders
  • Diet, Metabolism, and Disease
  • Liver physiology and pathology
  • Liver Disease and Transplantation
  • Liver Diseases and Immunity
  • Phagocytosis and Immune Regulation

Feldstein's frequent co-authors include Benedikt Kaufmann, Aleksandra Leszczynska, Hal M. Hoffman, Agustina Reca, and Alexander Wree, reflecting collaborative research efforts in their primary scientific interests.

Their publications have appeared in several key journals within the field, reflecting both interdisciplinary and focused contributions. The most frequent publication venues are:

  • Gastroenterology
  • Seminars in Liver Disease
  • Hepatology
  • Cell Reports
  • EMBO Reports

Notable recent papers by Ariel E. Feldstein include:

  • Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH, 2021, Cell Reports
  • Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH, 2020, Hepatology Communications
  • The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis, 2020, Seminars in Liver Disease
  • Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity, 2021, Seminars in Liver Disease
  • Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis, 2022, Hepatology

Best Publications

  • Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

    Zeneng Wang;Elizabeth Klipfell;Brian J. Bennett;Robert A. Koeth

  • The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

    Leon A. Adams;James F. Lymp;Jenny St. Sauver;Schuyler O. Sanderson

  • Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.

    Ariel E Feldstein;Ali Canbay;Paul Angulo;Makiko Taniai

  • Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway

    Ariel E. Feldstein;Nathan W. Werneburg;Ali Canbay;Maria Eugenia Guicciardi

  • NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.

    Auvro R. Mridha;Alexander Wree;Alexander Wree;Avril A.B. Robertson;Matthew M. Yeh

  • NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice.

    Alexander Wree;Akiko Eguchi;Matthew D. McGeough;Carla A. Pena

  • In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

    Anna Wieckowska;Nizar N. Zein;Lisa M. Yerian;A. Rocio Lopez

  • The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

    Ariel E Feldstein;Phunchai Charatcharoenwitthaya;Sombat Treeprasertsuk;Joanne T Benson

  • Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study†

    Ariel E. Feldstein;Anna Wieckowska;A. Rocio Lopez;Yao-Chang Liu

  • Triggering and resolution of inflammation in NASH.

    Susanne Schuster;Daniel Cabrera;Marco Arrese;Ariel E Feldstein

  • Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.

    Anna Wieckowska;Bettina G Papouchado;ZhengZheng Li;Rocio Lopez

  • From NAFLD to NASH to cirrhosis—new insights into disease mechanisms

    Alexander Wree;Lori Broderick;Ali Canbay;Hal M. Hoffman

  • Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.

    Anna Wieckowska;Arthur J. McCullough;Ariel E. Feldstein

  • Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression.

    Ali Canbay;Ariel E. Feldstein;Hajime Higuchi;Nate Werneburg

  • Innate Immunity and Inflammation in NAFLD/NASH.

    Marco Arrese;Daniel Cabrera;Alexis M. Kalergis;Ariel E. Feldstein;Ariel E. Feldstein

  • NLRP3 inflammasome activation is required for fibrosis development in NAFLD.

    Alexander Wree;Matthew D. McGeough;Carla A. Peña;Martin Schlattjan

  • Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.

    Zheng Zheng Li;Michael Berk;Thomas M. McIntyre;Ariel E. Feldstein

  • Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal.

    Naim Alkhouri;Laura J Dixon;Ariel E Feldstein

  • Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial

    Claudia Ortiz Zein;Claudia Ortiz Zein;Claudia Ortiz Zein;Lisa M. Yerian;Prema Gogate;Rocio Lopez

  • High‐fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis

    Rohit Kohli;Michelle Kirby;Stavra A. Xanthakos;Samir Softic

Frequent Co-Authors

Naim Alkhouri
Naim Alkhouri The University of Texas at Austin
Rocio Lopez
Rocio Lopez Cleveland Clinic
Valerio Nobili
Valerio Nobili Sapienza University of Rome
Gregory J. Gores
Gregory J. Gores Mayo Clinic
Michael Berk
Michael Berk Deakin University
Hal M. Hoffman
Hal M. Hoffman University of California, San Diego
Paul Angulo
Paul Angulo University of Kentucky
Craig J. McClain
Craig J. McClain University of Louisville
Leon A. Adams
Leon A. Adams University of Western Australia
Laura E. Nagy
Laura E. Nagy Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a career in medicine in the USA but are interested in alternative or related pathways, there are many flexible online degree options available. Healthcare professionals often look for accelerated programs to quickly advance their education and career. For example, those seeking to become advanced practice nurses may benefit from the quickest dnp program options designed for speed and convenience.

Similarly, the 1 year dnp program online appeals to working nurses eager to obtain advanced credentials in just twelve months. Entry-level pathways, such as the lpn fast track program, are ideal for individuals wanting to start their nursing career quickly and at a lower cost.

For those interested in mental health, advancing with a pmhnp online programs can lead to rewarding roles in psychiatric nursing. Each of these online programs offers flexibility, faster completion times, and opens up a variety of career opportunities in the health sector.

Best Scientists Citing Ariel E. Feldstein

Trending Scientists